mk 0663 has been researched along with Alzheimer Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghosh, T; Sil, S | 2 |
Aggarwal, S; Bhateja, D; Dhull, DK; Dhull, RK; Jindal, A; Padi, SS | 1 |
3 other study(ies) available for mk 0663 and Alzheimer Disease
Article | Year |
---|---|
Role of cox-2 mediated neuroinflammation on the neurodegeneration and cognitive impairments in colchicine induced rat model of Alzheimer's Disease.
Topics: Alzheimer Disease; Analysis of Variance; Animals; Cognition Disorders; Colchicine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Etoricoxib; Injections, Intraventricular; Male; Maze Learning; Neurodegenerative Diseases; Plaque, Amyloid; Pyridines; Rats; Sulfones; Time Factors | 2016 |
Cox-2 Plays a Vital Role in the Impaired Anxiety Like Behavior in Colchicine Induced Rat Model of Alzheimer Disease.
Topics: Alzheimer Disease; Animals; Anxiety; Behavior, Animal; Colchicine; Corticosterone; Cyclooxygenase 2; Disease Models, Animal; Etoricoxib; Male; Memory; Pyridines; Rats; Sulfones | 2016 |
Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer's disease in rats.
Topics: Alzheimer Disease; Animals; Antibiotics, Antineoplastic; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Etoricoxib; Injections, Intraventricular; Lipid Peroxidation; Male; Neuroprotective Agents; Pyridines; Rats; Rats, Wistar; Salicylates; Streptozocin; Sulfones | 2012 |